Compound Detail
CHEMBL221991
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL221991 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | IIMCLZRVLAPXDI-XNTDXEJSSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
6
Publications
0
Known Names
Molecular Properties
396.4
MW (Da)
0.22
ALogP
7
HBA
2
HBD
105.7
PSA (Ų)
0.62
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 5.21
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Falcipain 2 CHEMBL5800 | IC50 | 5.21 | 5.21 | 6200.0 | 1 |
| Cysteine protease falcipain-3 CHEMBL4510 | IC50 | 4.93 | 4.93 | 11800.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Falcipain 2 | IC50 | = | 6200.0 | nM | 5.21 | Inhibition of Plasmodium falciparum recombinant falcipain-2 | 15588096 |
| Cysteine protease falcipain-3 | IC50 | = | 11800.0 | nM | 4.93 | Inhibition of Plasmodium falciparum recombinant falcipain-3 | 15588096 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 15588096 | 10.1021/jm0493717 | Plasmodium falciparum | 2 |
| 15588096 | 10.1021/jm0493717 | Falcipain 2 | 1 |
| 15588096 | 10.1021/jm0493717 | Cysteine protease falcipain-3 | 1 |
| 15588096 | 10.1021/jm0493717 | Leishmania donovani | 1 |
| 15588096 | 10.1021/jm0493717 | Vero | 1 |
| 15588096 | 10.1021/jm0493717 | Cysteine protease | 1 |
Data from ChEMBL 36 via Core Engine